Search research articles
Contact Us
Filters
Showing results (81-90 of 131) with videos related to
Page
of 14
Sort By:
Plos One
|
December 3, 2020
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department
Donia Bouzid, Jimmy Mullaert, Quentin Le Hingrat, et al.
Viruses
|
August 28, 2021
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
Nathan Peiffer-Smadja, Antoine Bridier-Nahmias, Valentine Marie Ferré, et al.
The Journal of Antimicrobial Chemotherapy
|
February 8, 2018
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients
Alexandre Storto, Benoit Visseaux, Mélanie Bertine, et al.
The Journal of Infection
|
November 22, 2021
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
Samuel Lebourgeois, Reyene Menidjel, Houssem Redha Chenane, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 12, 2020
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
Charlotte Charpentier, Houria Ichou, Florence Damond, et al.
Frontiers in Immunology
|
November 17, 2022
Differential activation of human neutrophils by SARS-CoV-2 variants of concern
Samuel Lebourgeois, Ambroise David, Houssem Redha Chenane, et al.
Antimicrobial Agents and Chemotherapy
|
September 29, 2020
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity"
Minh Patrick Lê, Christine Le Beller, Quentin Le Hingrat, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 26, 2021
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
Samuel Lebourgeois, Alexandre Storto, Bernard Gout, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2021
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial
Donia Bouzid, Enrique Casalino, Jimmy Mullaert, et al.
Frontiers in Cellular and Infection Microbiology
|
January 3, 2022
Earlier <i>In Vitro</i> Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
Samuel Lebourgeois, Houssem Redha Chenane, Nadhira Houhou-Fidouh, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 131) with videos related to
Sort By:
Page
of 14
Plos One
|
December 3, 2020
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department
Donia Bouzid, Jimmy Mullaert, Quentin Le Hingrat, et al.
Viruses
|
August 28, 2021
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
Nathan Peiffer-Smadja, Antoine Bridier-Nahmias, Valentine Marie Ferré, et al.
The Journal of Antimicrobial Chemotherapy
|
February 8, 2018
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients
Alexandre Storto, Benoit Visseaux, Mélanie Bertine, et al.
The Journal of Infection
|
November 22, 2021
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
Samuel Lebourgeois, Reyene Menidjel, Houssem Redha Chenane, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 12, 2020
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
Charlotte Charpentier, Houria Ichou, Florence Damond, et al.
Frontiers in Immunology
|
November 17, 2022
Differential activation of human neutrophils by SARS-CoV-2 variants of concern
Samuel Lebourgeois, Ambroise David, Houssem Redha Chenane, et al.
Antimicrobial Agents and Chemotherapy
|
September 29, 2020
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity"
Minh Patrick Lê, Christine Le Beller, Quentin Le Hingrat, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 26, 2021
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
Samuel Lebourgeois, Alexandre Storto, Bernard Gout, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2021
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial
Donia Bouzid, Enrique Casalino, Jimmy Mullaert, et al.
Frontiers in Cellular and Infection Microbiology
|
January 3, 2022
Earlier <i>In Vitro</i> Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
Samuel Lebourgeois, Houssem Redha Chenane, Nadhira Houhou-Fidouh, et al.
Page
of 14